Takeda Pharmaceutical's Total Non-Current Liabilities fell 892.04% to $33.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $33.5 billion, marking a year-over-year decrease of 892.04%. This contributed to the annual value of $31.5 billion for FY2025, which is 1759.92% down from last year.
Per Takeda Pharmaceutical's latest filing, its Total Non-Current Liabilities stood at $33.5 billion for Q4 2025, which was down 892.04% from $35.3 billion recorded in Q3 2025.
Takeda Pharmaceutical's 5-year Total Non-Current Liabilities high stood at $56.3 billion for Q1 2021, and its period low was $31.5 billion during Q1 2025.
Over the past 5 years, Takeda Pharmaceutical's median Total Non-Current Liabilities value was $38.0 billion (recorded in 2024), while the average stood at $40.2 billion.
Per our database at Business Quant, Takeda Pharmaceutical's Total Non-Current Liabilities tumbled by 2628.69% in 2022 and then skyrocketed by 455.22% in 2024.
Takeda Pharmaceutical's Total Non-Current Liabilities (Quarter) stood at $48.9 billion in 2021, then fell by 26.29% to $36.0 billion in 2022, then dropped by 2.42% to $35.2 billion in 2023, then grew by 4.55% to $36.8 billion in 2024, then fell by 8.92% to $33.5 billion in 2025.
Its Total Non-Current Liabilities was $33.5 billion in Q4 2025, compared to $35.3 billion in Q3 2025 and $34.3 billion in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value